Search

everythinglearnresearchcommunity

for

Search:↓

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Treat pattern hair loss with finasteride and topical minoxidil.

No definitive link between finasteride and male breast cancer, but further research is needed.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

Excessive cell phone use may cause hair loss due to electromagnetic radiation.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Treating melasma in men is difficult, especially for the deeper skin layers, and may need more than just topical treatments.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

Finasteride improves hair growth in men with androgenetic alopecia.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.